Dr
Amy
Dawson

Trainee Patent Attorney

Glasgow Office

Telephone. +44(0) 141 229 5800
Email. [email protected]

Experience

Amy joined HGF's Glasgow office in May 2020 as a trainee patent attorney within the Life Sciences team.

She graduated from the University of Glasgow in 2016 with a first-class MSci in Immunology with Work Placement. This included a 12-month placement at GlaxoSmithKline R&D. She was awarded the Fyfe & Arthritis Research Campaign Prize for the best final year student in Immunology.

Amy completed a PhD in Cancer Studies from the University of Glasgow in March 2020. Her research involved using single cell RNA sequencing technology and proteomics to investigate the interaction of leukaemic stem cells and immune cells in the cancer microenvironment. During this time she also undertook an internship in technical transfer, which gave her experience in University spin-outs and the process of commercialising novel technologies.

Specialisms

  • Cell and gene therapy
  • Gene editing technologies
  • Immunobiology

Industries

  • Healthcare icon Healthcare
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Patents

Qualifications

Trainee


MSCI

MSci in Immunology

PHD

PhD in Cancer Sciences

Publications

The EPO ‘How To’ guide for antibody applications in Europe

View publication online

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details
Event - 25th May 2021

IAM webinar: How to capitalise on the 5G healthcare revolution

HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.